Literature DB >> 15452250

Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2.

Erin M Bennett1, Andrew M L Lever, Jane F Allen.   

Abstract

Using a yeast two-hybrid screen of a T-cell cDNA library to identify cellular proteins that bind to the human immunodeficiency virus type 2 (HIV-2) Gag polyprotein, we identified PRP4, a serine-threonine protein kinase. Specific interaction of PRP4 and HIV-2 Gag was confirmed in in vitro and in vivo assays. The interacting region of HIV-2 Gag is located in the conserved matrix and capsid domains, while both the RS (arginine-serine-rich) domain and the KS (kinase) domain of PRP4 are able to bind to HIV-2 Gag. PRP4 is not incorporated into virus particles. HIV-2 Gag is able to inhibit PRP4-mediated phosphorylation of the splicing factor SF2. This is also observed with Gag from simian immunodeficiency virus, a closely related virus, but not with Gag from human T-cell lymphotropic virus type 1. Our results provide evidence for a novel interaction between Gag and a cellular protein kinase involved in the control of constitutive splicing in two closely related retroviruses. We hypothesize that as Gag accumulates in the cell, down regulation of splicing occurs through reduced phosphorylation of SF2. At late stages of infection, this interaction may replace the function of the early viral regulatory protein Rev.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452250      PMCID: PMC521795          DOI: 10.1128/JVI.78.20.11303-11312.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 2.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions.

Authors:  K Gupta; D Ott; T J Hope; R F Siliciano; J D Boeke
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.

Authors:  S D Griffin; J F Allen; A M Lever
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Cloning of human PRP4 reveals interaction with Clk1.

Authors:  T Kojima; T Zama; K Wada; H Onogi; M Hagiwara
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

7.  Identification of a host protein essential for assembly of immature HIV-1 capsids.

Authors:  Concepcion Zimmerman; Kevin C Klein; Patti K Kiser; Aalok R Singh; Bonnie L Firestein; Shannyn C Riba; Jaisri R Lingappa
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

8.  SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.

Authors:  T Ø Tange; J Kjems
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

9.  The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.

Authors:  Barbara Müller; Tilo Patschinsky; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

View more
  4 in total

1.  Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches.

Authors:  Qiang Gao; Ingrid Mechin; Nayantara Kothari; Zhuyan Guo; Gejing Deng; Kimberly Haas; Jessica McManus; Dietmar Hoffmann; Anlai Wang; Dmitri Wiederschain; Jennifer Rocnik; Werngard Czechtizky; Xin Chen; Larry McLean; Heike Arlt; David Harper; Feng Liu; Tahir Majid; Vinod Patel; Christoph Lengauer; Carlos Garcia-Echeverria; Bailin Zhang; Hong Cheng; Marion Dorsch; Shih-Min A Huang
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

2.  CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.

Authors:  Reem Berro; Caitlin Pedati; Kylene Kehn-Hall; Weilin Wu; Zachary Klase; Yasmine Even; Anne-Marie Genevière; Tatiana Ammosova; Sergei Nekhai; Fatah Kashanchi
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription.

Authors:  Boli Huang; Yong-Tae Ahn; Lisa McPherson; Carol Clayberger; Alan M Krensky
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

Review 4.  Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond.

Authors:  Florentin Pastor; Lulzim Shkreta; Benoit Chabot; David Durantel; Anna Salvetti
Journal:  Front Microbiol       Date:  2021-03-29       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.